These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients. Sakurai M, Kunimoto H, Watanabe N, Fukuchi Y, Yuasa S, Yamazaki S, Nishimura T, Sadahira K, Fukuda K, Okano H, Nakauchi H, Morita Y, Matsumura I, Kudo K, Ito E, Ebihara Y, Tsuji K, Harada Y, Harada H, Okamoto S, Nakajima H. Leukemia; 2014 Dec; 28(12):2344-54. PubMed ID: 24732596 [Abstract] [Full Text] [Related]
3. In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis. Michaud J, Wu F, Osato M, Cottles GM, Yanagida M, Asou N, Shigesada K, Ito Y, Benson KF, Raskind WH, Rossier C, Antonarakis SE, Israels S, McNicol A, Weiss H, Horwitz M, Scott HS. Blood; 2002 Feb 15; 99(4):1364-72. PubMed ID: 11830488 [Abstract] [Full Text] [Related]
4. [Familial leukemia due to germline RUNX1 mutations: lessons learned from two decades of research and unsolved problems]. Osato M, Nambu A. Rinsho Ketsueki; 2020 Feb 15; 61(6):687-696. PubMed ID: 32624544 [Abstract] [Full Text] [Related]
6. Helicase-like transcription factor is a RUNX1 target whose downregulation promotes genomic instability and correlates with complex cytogenetic features in acute myeloid leukemia. Cheng CK, Chan NP, Wan TS, Lam LY, Cheung CH, Wong TH, Ip RK, Wong RS, Ng MH. Haematologica; 2016 Apr 15; 101(4):448-57. PubMed ID: 26802049 [Abstract] [Full Text] [Related]
7. Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy. Owen CJ, Toze CL, Koochin A, Forrest DL, Smith CA, Stevens JM, Jackson SC, Poon MC, Sinclair GD, Leber B, Johnson PR, Macheta A, Yin JA, Barnett MJ, Lister TA, Fitzgibbon J. Blood; 2008 Dec 01; 112(12):4639-45. PubMed ID: 18723428 [Abstract] [Full Text] [Related]
9. High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder. Preudhomme C, Renneville A, Bourdon V, Philippe N, Roche-Lestienne C, Boissel N, Dhedin N, André JM, Cornillet-Lefebvre P, Baruchel A, Mozziconacci MJ, Sobol H. Blood; 2009 May 28; 113(22):5583-7. PubMed ID: 19357396 [Abstract] [Full Text] [Related]
12. Hematopoietic stem cells acquire survival advantage by loss of RUNX1 methylation identified in familial leukemia. Matsumura T, Nakamura-Ishizu A, Muddineni SSNA, Tan DQ, Wang CQ, Tokunaga K, Tirado-Magallanes R, Sian S, Benoukraf T, Okuda T, Asou N, Matsuoka M, Osato M, Suda T. Blood; 2020 Oct 22; 136(17):1919-1932. PubMed ID: 32573733 [Abstract] [Full Text] [Related]
13. [A new form of familial platelet disorder caused by germline mutations in RUNX1 in a pedigree]. Guan J, Wang LL, Wang CY, Zhu XM, Shuai HZ, Yi X, Zou L, Yu D, Cheng H. Zhonghua Nei Ke Za Zhi; 2023 Apr 01; 62(4):393-400. PubMed ID: 37032134 [Abstract] [Full Text] [Related]
17. Unrelated hematopoietic stem cell transplantation for familial platelet disorder/acute myeloid leukemia with germline RUNX1 mutations. Toratani K, Watanabe M, Kanda J, Oka T, Hyuga M, Arai Y, Iwasaki M, Sakurada M, Nannya Y, Ogawa S, Yamada T, Takaori-Kondo A. Int J Hematol; 2023 Sep 01; 118(3):400-405. PubMed ID: 36897502 [Abstract] [Full Text] [Related]
19. Runx1/AML-1 ranks as a master regulator of adult hematopoiesis. Ichikawa M, Asai T, Chiba S, Kurokawa M, Ogawa S. Cell Cycle; 2004 Jun 01; 3(6):722-4. PubMed ID: 15213471 [Abstract] [Full Text] [Related]
20. Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation. Heller PG, Glembotsky AC, Gandhi MJ, Cummings CL, Pirola CJ, Marta RF, Kornblihtt LI, Drachman JG, Molinas FC. Blood; 2005 Jun 15; 105(12):4664-70. PubMed ID: 15741216 [Abstract] [Full Text] [Related] Page: [Next] [New Search]